H
Hengrui Pharma Tech Stack
Global pharmaceutical R&D and manufacturing with oncology and immunology focus
Hengrui Pharma operates a sprawling R&D organization (14 centers, 5,500+ professionals) spanning oncology, immunology, metabolic disease, and neuroscience, supported by a standard pharma tech stack (Python, Java, AWS, Azure, LIMS, CDISC, FHIR). Current hiring is heavily skewed toward research and director-level roles—23 of 48 active positions target R&D—while manufacturing and commercial functions remain thin, suggesting a company in preclinical and early clinical expansion rather than aggressive commercialization.
Tech Stack 20 technologies
Core StackPython Java C# AWS Jira Confluence Azure SQL Microsoft Project LIMS CDISC FHIR Excel PowerPoint Microsoft Office
AdoptingScrum Kanban
What Hengrui Pharma Is Building
◆Challenges
- Managing cross-functional regulatory submissions
- Recruiting quality management staff
- Accelerating drug approval
- Identifying high-value therapeutic targets
- Ensuring gmp compliance
- Negotiating deals
- Clinical trial safety
- Cross-functional coordination
- Lack of technical tools and data platforms
- Access barriers
▲Active Projects
- Paco quality system building
- Market research
- Clinical development strategy plan
- Preclinical target validation studies
- Antibody drug and adc development projects
- Clinical research system development
- Real-world evidence studies
- Annual regulatory plan development
- Mah contract manufacturing management
- Submission and sample testing
Hiring Activity
50 roles · 10 in 30d
Department
Seniority
Notable leadership hires: QA Director, Clinical Medicine Director, Immunology Director, Biology Director, Discovery Chemistry Director
Company intelligence
